000 01070 am a22002413u 4500
042 _adc
100 1 0 _aHowes, Oliver D
_eauthor
_91606
700 1 0 _aBarnes, Thomas
_eauthor
_91607
700 1 0 _aLennox, Belinda
_eauthor
_91608
700 1 0 _aMarkham, Sarah
_eauthor
_91609
700 1 0 _aNatesan, Sridhar
_eauthor
_91610
245 0 0 _aTime to re-evaluate the risks and benefits of valproate and a call for action
260 _c2022-12.
500 _a/pmc/articles/PMC7613842/
500 _a/pubmed/35795925
520 _aValproate is widely used in psychiatry and neurology, including off-label use. Here we consider its potential benefits and risks, particularly in women of child-bearing potential, and the evidence that clinical guidelines are adhered to. Finally, we consider the implications for clinical practice and research into its efficacy in off-label indications.
540 _a
546 _aen
690 _aArticle
655 7 _aText
_2local
786 0 _nBr J Psychiatry
856 4 1 _uhttp://dx.doi.org/10.1192/bjp.2022.94
_zConnect to this object online.
999 _c817
_d817